Insulin-like-growth-factor-I enhances proliferation and differentiation of human mesenchymal stromal cells in vitro

Joyce Doorn, Scott J. Roberts, Janneke Hilderink, Nathalie Groen, Aart A. van Apeldoorn, Clemens van Blitterswijk, Jan Schrooten, Jan de Boer

Research output: Contribution to journalArticleAcademicpeer-review

17 Citations (Scopus)
12 Downloads (Pure)

Abstract

Human mesenchymal stromal cells (hMSCs) offer great potential for bone tissue engineering applications, but their in vivo performance remains limited. Pre-conditioning of these cells with small molecules to improve their differentiation prior to implantation or incorporation of growth factors are possible solutions. Insulin-like growth factor-1 (IGF-1) is one of the most abundant growth factors in bone, involved in growth, development and metabolism, but its effects on hMSCs are still subject of debate. Herein, we examined the effects of IGF-1 on proliferation and differentiation of hMSCs in vitro and we found that serum abolished the effects of IGF-1. Only in the absence of serum, IGF-1 increased proliferation, ALP expression and osteogenic gene expression of hMSCs. Furthermore, we examined synergistic effects of BMP-2 and IGF-1 and, although IGF-1 enhanced BMP-2-induced mineralization, IGF-1 only slightly affected in vivo bone formation.
Original languageEnglish
Pages (from-to)1817-1828
JournalTissue engineering. Part A
Volume19
Issue number15-16
DOIs
Publication statusPublished - 26 Mar 2013

Keywords

  • IR-85274
  • METIS-295429

Fingerprint

Dive into the research topics of 'Insulin-like-growth-factor-I enhances proliferation and differentiation of human mesenchymal stromal cells in vitro'. Together they form a unique fingerprint.

Cite this